Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q2 2017 · 10-Q
Revenue$6.64B$6.64B+24.5% vs Q2 2016 Net Income$283.00M$283.00M−54.0% vs Q2 2016 EPS Diluted$0.16$0.16−61.0% vs Q2 2016 Gross Profit$3,056,000,000+5.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,351,000,000+48.6% Free Cash Flowderived$1,096,000,000+65.6% Margins · derivedGross margin46.0%−8.4 pt vs Q2 2016
Operating margin5.8%−9.5 pt vs Q2 2016
Net margin4.3%−7.3 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 2, 2017 · 33 d after period end